Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.50 |
| ▸ | PGR | P06401 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.50 |
| ▸ | DGKA | P23743 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL53665 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL9571592 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL1006866 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL27637046 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL25329633 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL514798 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL25330787 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL8429929 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL817977 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| Ammonia Solution, Strong SCHEMBL3968809 | 0.98 | ALDH1A1 (0.65) | ALDH1A1LMNATSHRCYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10199638-B2 | Composite anode active material, method of preparing the same, and anode and lithium secondary battery including the composite anode active material | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-02-05 | — | — | US | claimed |
| CN-105742584-A | Composite anode active material, method of preparing the same, and anode and lithium secondary battery | 三星电子株式会社 | 2016-07-06 | — | — | CN | claimed |
| US-20160190548-A1 | COMPOSITE ANODE ACTIVE MATERIAL, METHOD OF PREPARING THE SAME, AND ANODE AND LITHIUM SECONDARY BATTERY INCLUDING THE COMPOSITE ANODE ACTIVE MATERIAL | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-06-30 | — | — | US | claimed |
| US-20190284152-A1 | Maleinated Derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2019-09-19 | — | — | US | disclosed |
| US-10294210-B2 | Maleinated derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2019-05-21 | — | — | US | disclosed |
| US-10199638-B2 | Composite anode active material, method of preparing the same, and anode and lithium secondary battery including the composite anode active material | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-02-05 | — | — | US | disclosed |
| US-20180111912-A1 | Maleinated Derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2018-04-26 | — | — | US | disclosed |
| US-9896424-B2 | Methods of making sulfurized derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2018-02-20 | — | — | US | disclosed |
| US-9738618-B2 | Malienated derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2017-08-22 | — | — | US | disclosed |
| US-20160355492-A1 | Methods of Making Sulfurized Derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2016-12-08 | — | — | US | disclosed |
| US-9440891-B2 | Palladium-catalyzed decarbonylation of fatty acid anhydrides for the production of linear alpha olefins | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2016-09-13 | — | — | US | disclosed |
| CN-1737016-A | Polar group-containing olefin copolymer, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS INC (JP) | 2006-02-22 | — | — | CN | disclosed |
| CN-1737017-A | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS INC (JP) | 2006-02-22 | — | — | CN | disclosed |
| CN-1219800-C | Polar group-containing olefin copolymer, thermoplastic resin composition containing the same, and use thereof | MITSUI CHEMICALS INC (JP) | 2005-09-21 | — | — | CN | disclosed |
| CN-1639187-A | Macrocyclic peptides active against the hepatitis C virus | BOEHRINGER INGELHEIM CA LTD (CA) | 2005-07-13 | — | — | CN | disclosed |
| US-20040122192-A1 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS, INC. | 2004-06-24 | — | — | US | disclosed |
| CN-1414941-A | Compounds having hydroxycarbonyl-haloalkyl side chains | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2003-04-30 | — | — | CN | disclosed |
| US-20020156207-A1 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2002-10-24 | — | — | US | disclosed |
| CN-1342715-A | Polar group-containing olefin copolymer, process for producing the same, thermoplastic resin composition containing the same, and use thereof | MITSUI CHEMICALS INC (JP) | 2002-04-03 | — | — | CN | disclosed |
| EP-1186619-A2 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition contaning the copolymer, and uses thereof | Mitsui Chemicals, Inc. (JP) | 2002-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180111912-A1 | Maleinated Derivatives | SMOX, SRM, PADI2 | ALDH1A1 383/4885LMNA 1847/4885TSHR 4723/4885 |
| US-20190284152-A1 | Maleinated Derivatives | SMOX, SRM, PADI2 | ALDH1A1 383/4885LMNA 1847/4885TSHR 4723/4885 |
| US-20160355492-A1 | Methods of Making Sulfurized Derivatives | GPX4, CBS, ESD | ALDH1A1 769/4885LMNA 4738/4885TSHR 4776/4885 |
| US-10294210-B2 | Maleinated derivatives | SMOX, SRM, PADI2 | ALDH1A1 385/4885LMNA 1892/4885TSHR 4719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.